Large vessel stenosis is currently successfully treated with percutaneous stent implantation. Zephyr stent is a cobalt-chromium peripheral stent specifically designed for large-vessel stenting. Its specific "S-" and "C-" shaped flexible polylinks prevent stent foreshortening and recoil. We report our experience of using Zephyr among the pediatric population and their medium-term outcome. The study included a total of 19 patients treated with 21 Zephyr stents. The indications for stenting included coarctation of the aorta (four patients), stenosed pulmonary artery (eight patients), stenosed right ventricular outflow tract (five patients) or conduit (one patient), and percutaneous Fontan (one patient). All the procedures were successful. None of the patients showed any stent-related complications. Stent fractures, foreshortening, or recoil were not seen during follow-up. Our medium-term (1-20 months) follow-up showed a favorable outcome. One patient developed restenosis. Zephyr stent is a good therapeutic option for large-vessel stenting. However, it needs large-scale studies for further confirmation.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10856609 | PMC |
| http://dx.doi.org/10.4103/apc.apc_78_23 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Pediatric cardiac interventions: Innovations from India.
Ann Pediatr Cardiol
November 2024
Department of Cardiology, All India Institute of Medical Sciences, New Delhi, India.
India, owing to its population structure, faces an enormous burden of children born with congenital heart disease (CHD). Systematic challenges such as limited public health infrastructure, a shortage of trained specialists, and high out-of-pocket expenditures hinder uniform access to comprehensive CHD care. Despite these limitations, Indian pediatric cardiologists have delivered innovative and often cost-effective solutions to challenging clinical problems.
View Article and Find Full Text PDFClinical Performance of the Low Profile Zenith Alpha Abdominal Endovascular Graft: 2 Year Results from the ZEPHYR Registry.
Eur J Vasc Endovasc Surg
July 2024
Department of Vascular Surgery, Catharina Hospital, Eindhoven, the Netherlands.
Article Synopsis
- The ZEPHYR registry evaluated the midterm outcomes of the low profile Zenith Alpha abdominal endovascular graft for treating non-ruptured abdominal aortic aneurysms in 347 patients across multiple European sites.
- The study found that treatment success rates were high at 6 months (92.5%), 1 year (90.4%), and 2 years (85.3%), with the main complications being related to limb issues.
- The researchers could not determine any specific factors that independently predicted limb complications, indicating a need for further investigation into these issues.
Use of Zephyr stent in congenital heart diseases: A single-center study.
Ann Pediatr Cardiol
January 2024
Department of Pediatric Cardiology, Apollo Children's Hospital, Chennai, Tamil Nadu, India.
Large vessel stenosis is currently successfully treated with percutaneous stent implantation. Zephyr stent is a cobalt-chromium peripheral stent specifically designed for large-vessel stenting. Its specific "S-" and "C-" shaped flexible polylinks prevent stent foreshortening and recoil.
View Article and Find Full Text PDFFirst-in-man use of an Indian-made balloon-expandable covered Zephyr stent and intermediate-term follow-up.
Ann Pediatr Cardiol
April 2023
Department of Pediatric Cardiology, Institute of Cardiovascular Diseases, Madras Medical Mission, Chennai, Tamil Nadu, India.
Covered stent is used in large-vessel angioplasty in anticipation of vessel wall injury. Apart from aortic coarctation, they are also used in dysfunctional right ventricular outflow conduits and find a recent role in transcatheter sinus venosus defect closure. Different methods of covering stents include glue fixation, sutureless lamination, sandwich, and sintering lamination.
View Article and Find Full Text PDFThirty-day Results from the ZEPHYR Registry: Outcomes of EVAR Using the Zenith Alpha™ Abdominal Endovascular Graft for the Treatment of AAA in 347 Patients.
Ann Vasc Surg
January 2022
Department of Vascular and Endovascular Surgery, University Hospital Heidelberg, Heidelberg, Germany.
Article Synopsis
- The ZEPHYR registry aimed to assess the 30-day outcomes of using the Zenith Alpha abdominal stent graft for treating abdominal aortic aneurysms (AAAs) in a multicenter study across Germany, Belgium, and The Netherlands from December 2016 to December 2019.
- A total of 347 patients were analyzed, mostly elderly with a median age of 73, and exhibited substantial technical (96%) and clinical (98.8%) success rates in the treatment of their AAAs.
- The study found a 30-day overall treatment success rate of 94.8%, with few complications reported, including 3 patients (0.9%) experiencing limb occlusions and 1 patient (0.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!